A Conceptual Paper Applying the Precede-Proceed Model to Person-Centred COPD Care: A Timely Resource for Patients, Clinicians, Health Organisations and Healthcare Policymakers
Chronic Obstructive Pulmonary Disease (COPD) is a progressive and irreversible obstructive lung condition. Its aetiology involves complex, cumulative interactions between genetic, lifestyle, and environmental factors throughout an individual’s lifespan. COPD impacts quality of life and economy in significant and diverse ways. This conceptual paper analyses the benefits of applying the Precede-Proceed Model to the clinical assessment, care, treatment, and evaluation of COPD patients in acute and community settings. The model provides a robust, systematic framework for addressing the multifaceted challenges of COPD management. Given COPD’s complex aetiology, which encompasses genetic predispositions, lifestyle choices, and environmental exposures, a comprehensive approach to intervention is essential. Hence, there is a critical need for healthcare professionals, researchers, policymakers, and patient advocacy groups to innovate and implement novel strategies to confront the escalating and persistent public health challenge posed by COPD. This comprehensive approach integrates aspects of COPD assessment and care that are adaptable across diverse healthcare settings, including home-based care, community interventions, acute care environments, and policy development. Employing the Precede-Proceed Model to holistically address COPD offers the potential to improve the quality of life and functional capacity of individuals with COPD, as well as the global economy, by identifying related non-biomedical blind spots, such as the psychological, social, and economic determinants of patient well-being.
References
[1]
World Health Organization (2024) Chronic Obstructive Pulmonary Disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
[2]
Global Initiative for Chronic Obstructive Lung Disease (2025) GOLD 2025 Report. https://goldcopd.org/2025-gold-report/
[3]
Thawanaphong, S. and Nair, P. (2025) Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease. Respirology, 30, 574-586. https://doi.org/10.1111/resp.70062
[4]
Martinez, F.J., Agusti, A., Celli, B.R., Han, M.K., Allinson, J.P., Bhatt, S.P., et al. (2022) Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward. AmericanJournalofRespiratoryandCriticalCareMedicine, 205, 275-287. https://doi.org/10.1164/rccm.202107-1663so
[5]
GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 385, 117-171.
[6]
Horner, A., Olschewski, H., Hartl, S., Valipour, A., Funk, G., Studnicka, M., et al. (2023) Physical Activity, Depression and Quality of Life in COPD—Results from the CLARA II Study. InternationalJournalofChronicObstructivePulmonaryDisease, 18, 2755-2767. https://doi.org/10.2147/copd.s435278
[7]
daCosta DiBonaventura, M., Paulose-Ram, R., Su, J., McDonald, M., Zou, K.H., Wagner, J., et al. (2012) The Impact of COPD on Quality of Life, Productivity Loss, and Resource Use among the Elderly United States Workforce. COPD: JournalofChronicObstructivePulmonaryDisease, 9, 46-57. https://doi.org/10.3109/15412555.2011.634863
[8]
Brien, S.B., Stuart, B., Dickens, A.P., Kendrick, T., Jordan, R.E., Adab, P., et al. (2018) Independent Determinants of Disease-Related Quality of Life in COPD—Scope for Nonpharmacologic Interventions? InternationalJournalofChronicObstructivePulmonaryDisease, 13, 247-256. https://doi.org/10.2147/copd.s152955
[9]
Jarab, A., Alefishat, E., Mukattash, T., Alzoubi, K. and Pinto, S. (2018) Patients’ Perspective of the Impact of COPD on Quality of Life: A Focus Group Study for Patients with COPD. InternationalJournalofClinicalPharmacy, 40, 573-579. https://doi.org/10.1007/s11096-018-0614-z
[10]
National Research Council (2012) Aging and the Macroeconomy: Long-Term Implications of an Older Population. 1 Edition, National Academies Press.
[11]
Green, L.W. and Kreuter, M.W. (1991) Health Promotion Planning: An Educational and Environmental Approach (Vol. 298). Mayfield Publishing Company.
[12]
Lael-Monfared, E., Rakhshanderou, S., Ramezankhani, A. and Ghaffari, M. (2022) Educational and Ecological Assessment for Unintentional Injuries among Children under 7 Years: Directed Qualitative Research Based on PRECEDE-PROCEED Model. InjuryPrevention, 28, 365-373. https://doi.org/10.1136/injuryprev-2022-044521
[13]
Beydokhti, T.B., Dehnoalian, A., Moshki, M. and Akbary, A. (2021) Effect of Educational‐Counseling Program Based on Precede‐Proceed Model during Pregnancy on Postpartum Depression. NursingOpen, 8, 1578-1586. https://doi.org/10.1002/nop2.770
[14]
Selvaraj, S.N. and Sriram, A. (2022) The Quality of Indian Obesity-Related Mhealth Apps: PRECEDE-PROCEED Model-Based Content Analysis. JMIRmHealthanduHealth, 10, e15719. https://doi.org/10.2196/15719
[15]
Odelli, S., Zeduri, M., Schivardi, M.R., Archi, D., Coppola, L., Genco Russo, R., et al. (2024) Impact of PRECEDE-PROCEED Model Audits in Cancer Screening Programs in Lombardy Region: Supporting Equity and Quality Improvement. CurrentOncology, 31, 5960-5973. https://doi.org/10.3390/curroncol31100445
[16]
Green, L.W. and Kreuter, M.W. (2005) Health Program Planning: An Educational and Ecological Approach (Vol. 4). McGraw-Hill.
[17]
Megari, K. (2013) Quality of Life in Chronic Disease Patients. HealthPsychologyResearch, 1, 27. https://doi.org/10.4081/hpr.2013.932
[18]
Patel, J., Coutinho, A., Lunacsek, O. and Dalal, A. (2018) COPD Affects Worker Productivity and Health Care Costs. InternationalJournalofChronicObstructivePulmonaryDisease, 13, 2301-2311. https://doi.org/10.2147/copd.s163795
[19]
Cabrita, B., Gonçalves, G., Cabrita, A. and Dias, S. (2021) Quality of Life in Chronic Obstructive Pulmonary Diseases. In: Esquinas, A.M., Ed., PulmonaryFunctionMeasurementinNoninvasiveVentilatorySupport, Springer International Publishing, 317-323. https://doi.org/10.1007/978-3-030-76197-4_43
[20]
Jarvis, C. (2004) Physical Examination & Health Assessment. 4th Edition, Saunders. https://go.exlibris.link/HM4rK8sC.
[21]
Jarvis, C. and Eckhardt, A.L. (2023) Physical Examination and Health Assessment E-Book. Elsevier Health Sciences.
[22]
Unal, A., Bayram, B., Ergan, B., Can, K., Ergun, Y.K. and Kilinc, O. (2022) Comparison of Two Scores for Short-Term Outcomes in Patients with COPD Exacerbation in the Emergency Department: The Ottawa COPD Risk Scale and the DECAF Score. ERJOpenResearch, 9, 00436-2022. https://doi.org/10.1183/23120541.00436-2022
[23]
O’Halloran, L., Purcell, A., Ryan, E., O’Doherty, J., Troddyn, L., Slepanek, M., et al. (2020) A Snapshot of Chronic Obstructive Pulmonary Disease Management in General Practice in Ireland. IrishJournalofMedicalScience, 190, 1055-1061. https://doi.org/10.1007/s11845-020-02435-9
[24]
Papi, A., Vestbo, J., Fabbri, L., Corradi, M., Prunier, H., Cohuet, G., et al. (2018) Extrafine Inhaled Triple Therapy versus Dual Bronchodilator Therapy in Chronic Obstructive Pulmonary Disease (TRIBUTE): A Double-Blind, Parallel Group, Randomised Controlled Trial. TheLancet, 391, 1076-1084. https://doi.org/10.1016/s0140-6736(18)30206-x
[25]
Buttery, S.C., Zysman, M., Vikjord, S.A.A., Hopkinson, N.S., Jenkins, C. and Vanfleteren, L.E.G.W. (2021) Contemporary Perspectives in COPD: Patient Burden, the Role of Gender and Trajectories of Multimorbidity. Respirology, 26, 419-441. https://doi.org/10.1111/resp.14032
[26]
Fabbri, L.M., Celli, B.R., Agustí, A., Criner, G.J., Dransfield, M.T., Divo, M., et al. (2023) COPD and Multimorbidity: Recognising and Addressing a Syndemic Occurrence. TheLancetRespiratoryMedicine, 11, 1020-1034. https://doi.org/10.1016/s2213-2600(23)00261-8
[27]
Goldenberg, M., Danovitch, I. and IsHak, W.W. (2014) Quality of Life and Smoking. TheAmericanJournalonAddictions, 23, 540-562. https://doi.org/10.1111/j.1521-0391.2014.12148.x
[28]
World Health Organization (2017) WHO Report on the Global Tobacco Epidemic 2017: Monitoring Tobacco Use and Prevention Policies. https://www.who.int/publications/i/item/9789241512824
[29]
World Health Organization (2021) WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000-2025. https://www.who.int/publications/i/item/9789240039322
[30]
Alanazi, A.M.M., Alqahtani, M.M., Alquaimi, M.M., Alotaibi, T.F., Algarni, S.S., Ismaeil, T.T., et al. (2021) Substance Use and Misuse among Adults with Chronic Obstructive Pulmonary Disease in the United States, 2015-2019: Prevalence, Association, and Moderation. InternationalJournalofEnvironmentalResearchandPublicHealth, 19, Article 408. https://doi.org/10.3390/ijerph19010408
[31]
Lewer, D., Cox, S., Hurst, J.R., Padmanathan, P., Petersen, I. and Quint, J.K. (2022) Burden and Treatment of Chronic Obstructive Pulmonary Disease among People Using Illicit Opioids: Matched Cohort Study in England. BMJMedicine, 1, e000215. https://doi.org/10.1136/bmjmed-2022-000215
[32]
Mulryan, K. (2025) Introducing a Network of Chronic Obstructive Pulmonary Disease (COPD) Multidisciplinary Teams (MDTs) Linked to Lung Volume Reduction Services in Ireland: Analysis of Health Economic Implications. Royal College of Surgeons in Ireland.
[33]
Abrahamsen, C.S., Lang‐Ree, H.M., Halvorsen, K. and Stenbakken, C.M. (2021) Patients with COPD: Exploring Patients’ Coping Ability during an Interdisciplinary Pulmonary Rehabilitation Programme: A Qualitative Focus Group Study. JournalofClinicalNursing, 30, 1479-1488. https://doi.org/10.1111/jocn.15700
[34]
COPD Support Ireland (2024) Living well with COPD. https://copd.ie/living-well-with-copd/
[35]
Sosnowski, R., Kulpa, M., Ziȩtalewicz, U., Wolski, J.K., Nowakowski, R., Bakuła, R. and Demkow, T. (2017) Basic Issues Concerning Health-Related Quality of Life. CentralEuropean Journal of Urology, 70, 206-211.
[36]
Haraldstad, K., Wahl, A., Andenæs, R., Andersen, J.R., Andersen, M.H., Beisland, E., et al. (2019) A Systematic Review of Quality of Life Research in Medicine and Health Sciences. QualityofLifeResearch, 28, 2641-2650. https://doi.org/10.1007/s11136-019-02214-9
[37]
Stolbrink, M., Thomson, H., Hadfield, R.M., Ozoh, O.B., Nantanda, R., Jayasooriya, S., et al. (2022) The Availability, Cost, and Affordability of Essential Medicines for Asthma and COPD in Low-Income and Middle-Income Countries: A Systematic Review. TheLancetGlobalHealth, 10, e1423-e1442. https://doi.org/10.1016/s2214-109x(22)00330-8
[38]
Semple, S., Dobson, R., O’Donnell, R., Zainal Abidin, E., Tigova, O., Okello, G., et al. (2022) Smoke-Free Spaces: A Decade of Progress, a Need for More? TobaccoControl, 31, 250-256. https://doi.org/10.1136/tobaccocontrol-2021-056556
[39]
Ivan, G. and Kohar, A. (2023) Comparative Study of Air Pollutant Levels in Smoke-Free Areas and Active Smoking Areas. JournalOfNursingPractice, 7, 169-175.
[40]
Thalib, T. (2025) Inhibitory Control and Empathy: A Study of Smoking in Public Places among Students. JournalofNursingScienceResearch, 2, 10-16. https://doi.org/10.33862/jnsr.v2i1.485
[41]
Pourchez, J., Mercier, C. and Forest, V. (2022) From Smoking to Vaping: A New Environmental Threat? TheLancetRespiratoryMedicine, 10, e63-e64. https://doi.org/10.1016/s2213-2600(22)00187-4